Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma

Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma

Challenges Johnson &Johnson’s Darzalex. Armed with new  phase 3 clinical results, Sanofi says its multiple myeloma drug Sarclisa should be considered the “treatment of choice” among CD38-targeting therapies, throwing ... down a gauntlet to

Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July

Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July That includes AstraZeneca, GlaxoSmithKline, Johnson &Johnson and Pfizer, as well as researchers at the University of Oxford and Imperial College London.

ASCO: Momentum gathers behind next wave of CAR-T therapies

ASCO: Momentum gathers behind next wave of CAR-T therapies big hit for Johnson &Johnson, whose CAR-T is trailing a Bristol-Myers Squibb therapy that is nevertheless closest to market.

IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine

IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine The CEOs of vaccine giants AstraZeneca, GlaxoSmithKline, Johnson &Johnson and Pfizer made the promise at a virtual media briefing convened by the IFPMA industry association yesterday.

EMA clears BMS’ oral multiple sclerosis drug Zeposia

EMA clears BMS’ oral multiple sclerosis drug Zeposia in the market but has been growing slowly – plus others in the pipeline from Johnson &Johnson and Mitsubishi Tanabe.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics